Canada markets close in 3 hours 41 minutes

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.8000-0.0500 (-2.70%)
As of 11:38AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close1.8500
Open1.9150
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.8000 - 1.9150
52 Week Range1.8000 - 6.2000
Volume12,082
Avg. Volume97,933
Market Cap13.755M
Beta (5Y Monthly)1.23
PE Ratio (TTM)N/A
EPS (TTM)-4.9600
Earnings DateApr 04, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJun 05, 2015
1y Target EstN/A
  • Insider Monkey

    Trinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Call Transcript

    Trinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Call Transcript April 4, 202 Trinity Biotech plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings! Welcome to the Trinity Biotech’s Fourth Quarter and Full Year 2023 Earnings Conference Call. At this […]

  • GuruFocus.com

    Trinity Biotech PLC (TRIB) Q4 2023 Earnings Call Transcript Highlights: A Glimpse into ...

    Trinity Biotech reveals Q4 results and strategic initiatives amidst a challenging fiscal year, setting the stage for a transformative 2024.

  • GlobeNewswire

    Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

    DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarter ended December 31, 2023 and fiscal year 2023 and key business updates. Business Updates Comprehensive Transformation Plan At the Emerging Growth Investor Conference on March 7, 2024, our new management team announced a comprehensive tra